Table 1 Clinical characteristic of patients with different HCV genotypes
From: SVR Rates of HCV-infected population under PEG-IFN-α/R treatment in Northwest China
HCV Genotype | No. | Age (y), range | Sex (No. of Patients, %) | Viral load (106 IU/mL), range | ALT (U/L), range | AST (U/L), range | |
|---|---|---|---|---|---|---|---|
Male | Female | ||||||
1a | 12 | 39.67 (24–60) | 7 (58.33) | 5 (41.67) | 2.33 (0.01–29.90) | 58.17 (19–249) | 37.08 (10–157) |
1b | 111 | 46.81 (20–79) | 52 (47.27) | 58 (52.73) | 1.62 (0.02–46.1) | 50.15 (13–392) | 44.96 (16–453) |
2a | 89 | 50.45 (22–80) | 40 (44.94) | 49 (55.06) | 2.60 (0.00–18.10) | 49.38 (12–554) | 35.25 (15–205) |
2b | 1 | 54.00 (54–54) | 0 (100.00) | 1 (0.00) | 1.08 | 286.00 | 351.00 |
3a | 11 | 37.91 (25–53) | 8 (72.73) | 3 (27.27) | 5.52 (0.21–29.5) | 91.27 (37–340) | 50.36 (32–160) |
3b | 5 | 38.00 (23–45) | 3 (60.00) | 2 (40.00) | 1.71 (0.10–6.88) | 52.40 (58–204) | 37.00 (44–141) |
4a | 0 | ||||||
5a | 1 | 43.00 (43–43) | 2 (100.00) | 0 (0.00) | 0.00 | 0.00 | 0.00 |
6a | 1 | 25.00 (25–25) | 1 (100.00) | 0 (0.00) | 0.00 | 0.00 | 0.00 |
Z = 3.6464 | chi-squared =0.643 | Z = 1.8797 | Z = 0.6820 | Z = 0.6820 | |||
P value | .067 | .836 | .113 | .605 | .605 | ||